FDA Proposes Withdrawal Of AMAG's Preterm Birth Drug Makena, Generics From Market

The FDA is proposing to withdraw AMAG Pharmaceuticals Inc.'s (AMAG) preterm birth drug Makena from the market because the required postmarket study failed to verify the clinical benefit of the drug.

from RTT - Biotech https://ift.tt/33xxxtw
via IFTTT